Clinical trial
Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting…
NCT00306748 · Ironwood Pharmaceuticals, Inc., Industry · Completed
Key facts
| NCT number | NCT00306748 |
|---|---|
| Title | Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation |
| Official title | A Randomized, Multicenter, Double-Blind, Parallel-Design, Phase 2 Trial of Oral MD-1100 Acetate Administered for 14 Days Once Daily at 100 ug, 300 ug, 1000 ug, or Placebo to Patients With Chronic Constipation |
| Lead sponsor | Ironwood Pharmaceuticals, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Constipation |
| Intervention type | Drug |
| Interventions | MD-1100 Acetate |
| Enrollment | 40 |
| Start date | Mar 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Mar 24, 2006 |
| Last update posted | Mar 24, 2009 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: